Global H1N1 Vaccine market growth 2024, Forecast To 2033
4 Mar, 2024
The H1N1 vaccine market has demonstrated robust growth, poised to rise from $3.16 billion in 2023 to$3.37 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. This growth is attributed to previous outbreaks, global health security concerns, vaccine development, and government initiatives. Forecasts suggest strong growth, with the market expected to reach $4.46 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The anticipated expansion is driven by broad-spectrum vaccine research, global health initiatives, resilience building, and vaccination integration. Major trends include pandemic preparedness, vaccination programs, cross-protection research, and technological advancements in manufacturing and surveillance.
Global H1N1 Vaccine Market Key Driver
The increase in expenditure for research and development activities in the field of immunology and vaccine is expected to propel the growth of the H1N1 vaccine market going forward. Immunology and vaccines are used to prevent infections and help in producing antibodies to fight infections. Immunology is a crucial area of research in the medical and biological sciences that focuses on understanding the immune system. The H1N1 vaccine is a preparation used to boost antibody production, which provides immunity against a variety of diseases. For instance, according to an article by the kENUP Foundation, a Europe-based non-profit supporting research-based innovation in health industries, in January 2021, governments spent at least $94.11 billion (€93 billion) on the development of vaccines and treatments since the start of the pandemic worldwide. The public sector committed 95% of the total spending, or $87.54 billion (€86.5 billion), in just 11 months to the development of vaccinations. Therefore, increasing expenditure for research and development activities in the field of immunology and vaccines is driving the growth of the H1N1 vaccine market. In 2023, the market size for H1N1 vaccines is valued at X, and it is projected to reach Y by 2028.
Get A Free Sample Of The Global H1N1 Vaccine Market ReportGlobal H1N1 Vaccine Market Segments
The global h1n1 vaccine market covered in this report is segmented –
1) By Product Type: Inactivated Vaccine, Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination
3) By End Users: Hospitals, Clinics, Research and Diagnostic Laboratories, Other End Users
By Geography: The regions covered in the h1n1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
North America was the largest region in the H1N1 vaccine market in 2023. The regions covered in the h1n1 vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major H1N1 Vaccine Industry Players
Sanofi SA, Novartis AG, GlaxoSmithKline PLC, CSL Limited, AstraZeneca Inc., Zydus Lifesciences Limited, Merck and Co.Inc., Novavax Inc., Baxter Laboratories Inc., Panacea Biotec Ltd., Sinovac Biotech Ltd., Green Cross Corp., Abbott Laboratories, Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Seqirus Ltd., Cipla Inc., Protein Sciences Corporation, Hualan Biological Engineering Inc., Changsheng Bio-Technology Co. Ltd., Takeda Pharmaceutical Ltd., Bharat Biotech International Limited, Serum Institute of India Pvt. Ltd., Bio Farma Group, PT Kalbe Farma Tbk, Daiichi Sankyo Chemical Pharma Co. Ltd., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Moderna Inc., CureVac NV, BioNTech SE, Inovio Pharmaceuticals Inc., Vaxart Inc., Altimmune Inc., Dynavax Technologies Corporation, VBI Vaccines Inc., GeoVax Labs Inc.
Get The Full Global H1N1 Vaccine Market Report
H1N1 Vaccine Market Overview
H1N1 vaccines are administered to people six months of age and older to immunize them against influenza diseases brought on by the H1N1 2009 virus. These are used to prevent humans from Influenza virus infection by injecting a small dose of the virus inside the body to build immunity against the virus.
H1N1 Vaccine Global Market Report 2023 provides data on the global h1n1 vaccine market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The h1n1 vaccine market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.